Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xiidra
Xiidra
In the Spirit of the Olympics: On and Off the Pharma Podium
PharmExec
Sat, 08/13/16 - 06:44 pm
Shire
Xiidra
Bayer
JNJ
beloranib
Zafgen
GSK
Valeant Pharmaceuticals
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Shire
Allergan
dry eye disease
Xiidra
Restasis
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
dry eye disease
Shire
Allergan
Xiidra
Restasis
Should Allergan Worry About Shire’s Win With Dry Eye Drug?
Bidness, ETC
Wed, 07/13/16 - 11:02 am
Allergan
Shire
dry eye disease
Restasis
Xiidra
Shire Secures Access to 16 Million-Strong US Dry Eye Disease Market With New Drug Approval
Forbes
Tue, 07/12/16 - 11:04 am
Shire
dry eye disease
FDA
Lifitegrast
Xiidra
Pages
« first
‹ previous
1
2